These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1596396)

  • 21. Interaction of clonidine and rilmenidine with imidazoline-preferring receptors.
    Lachaud V; Coupry I; Podevin RA; Dausse JP; Koenig E; Parini A
    J Hypertens Suppl; 1988 Dec; 6(4):S511-3. PubMed ID: 3241245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nature of [3H]rilmenidine binding to membranes of rat cerebral cortex.
    King PR; Gundlach AL; Jarrott B; Louis WJ
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):64S-68S. PubMed ID: 1350729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
    Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha 2-adrenoceptor and catecholamine-insensitive binding sites for [3H]rilmenidine in membranes from rat cerebral cortex.
    King PR; Gundlach AL; Jarrott B; Louis WJ
    Eur J Pharmacol; 1992 Jul; 218(1):101-8. PubMed ID: 1356804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit.
    Feldman J; Tibiriça E; Bricca G; Dontenwill M; Belcourt A; Bousquet P
    Br J Pharmacol; 1990 Jul; 100(3):600-4. PubMed ID: 2390682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
    Bruban V; Estato V; Schann S; Ehrhardt JD; Monassier L; Renard P; Scalbert E; Feldman J; Bousquet P
    Circulation; 2002 Mar; 105(9):1116-21. PubMed ID: 11877365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.
    Atlas D; Diamant S; Zonnenschein R
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):83S-90S. PubMed ID: 1317715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
    Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central actions of agmatine in conscious spontaneously hypertensive rats.
    Briaud S; Zhang BL; Sannajust F
    Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the pharmacology of rilmenidine.
    Montastruc JL; Macquin-Mavier I; Tran MA; Damase-Michel C; Koenig-Berard E; Valet P
    Am J Med; 1989 Sep; 87(3C):14S-17S. PubMed ID: 2571291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New concepts on the central regulation of blood pressure. Alpha 2-adrenoceptors and "imidazoline receptors".
    Bousquet P; Feldman J; Tibirica E; Bricca G; Molines A; Dontenwill M; Belcourt A
    Am J Med; 1989 Sep; 87(3C):10S-13S. PubMed ID: 2571290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.